Inhaled CBD Reverses Neurological Damage Caused by Nicotine Pouches, Study Finds

A recent study published in the scientific journal Nicotine & Tobacco Research revealed that repeated use of nicotine pouches can intensify the severity of seizures and brain inflammations. The research, led by the University of Augusta (USA), showed that inhaled CBD was able to reverse several of these adverse effects.

Treatment with cannabidiol restored brain functions impaired by chronic exposure to the product. The experiment compared the effects of acute and chronic exposure to nicotine pouches in animal models.

To measure neurological vulnerability, researchers used kainic acid to induce seizures. Continuous nicotine exposure made the episodes significantly more severe, a scenario where inhaled CBD demonstrated therapeutic efficacy.

Recovery of the Glymphatic System with Inhaled CBD

The authors investigated the biological causes behind the adverse reaction to nicotine. It was observed that chronic use compromised the functioning of the glymphatic system, a structure that acts as a "cleaning circuit" for metabolic waste in the brain.

Analyses also identified an increase in inflammation markers and neuronal stress. Nicotine induced the release of the protein IL-6, associated with inflammatory processes, and reduced the expression of AQP4, essential for fluid flow.

By administering inhaled CBD in the same animal model, the team observed a clear reversal of these damages. Cannabidiol brought protein levels and brain flow closer to normal levels.

Anti-Inflammatory Action of Inhaled CBD

The substance intervention decreased the severity of seizures and reduced inflammatory markers. Cellular tests indicated that inhaled CBD acted by suppressing the inflammatory response early on.

The data suggest that cannabidiol, in this administration route, not only protects against seizures exacerbated by nicotine. It also directly assists in restoring glymphatic function that had been impaired.

Market Context and Studies on Inhaled CBD

Nicotine pouches have gained popularity as a "discreet" alternative, but organizations like the German Federal Institute for Risk Assessment (BfR) warn of their dangers. The amount of absorbed nicotine can reach blood levels similar to those of a conventional cigarette.

Researchers emphasize that the results are promising for understanding the interaction between cannabinoids and damages from legal drugs. However, as the study on inhaled CBD was preclinical, new human tests are needed to validate medical application.

With information from Cáñhamo